Corient Capital Partners, LLC Abbott Laboratories Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Corient Capital Partners, LLC holds 56,753 shares of ABT stock, worth $6.48 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

56,753

Previous 56,753 -0.0%

Holding current value

$6.48 Million

Previous $6.17 Million -0.0%

% of portfolio

0.46%

Previous 0.47%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $170,967 - $206,644	1,675 Added 3.04%	56,753 $6.17 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $68,754 - $83,841	603 Added 1.11%	55,078 $6.52 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $95,312 - $116,704	825 Added 1.54%	54,475 $7.67 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $521,820 - $577,285	4,473 Added 9.1%	53,650 $6.34 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $514,774 - $605,962	4,866 Added 10.98%	49,177 $5.7 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $294,303 - $346,733	2,704 Added 6.5%	44,311 $5.31 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $767,655 - $836,524	-7,311 Reduced 14.95%	41,607 $4.56 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $119,773 - $145,456	-1,307 Reduced 2.6%	48,918 $5.32 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $208,346 - $266,658	2,721 Added 5.73%	50,225 $4.59 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $145,365 - $212,564	2,314 Added 5.12%	47,504 $3.75 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $106,459 - $118,514	1,356 Added 3.09%	45,190 $3.93 Million
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $282,348 - $306,153	3,450 Added 8.54%	43,834 $3.67 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $115,004 - $134,130	1,578 Added 4.07%	40,384 $3.4 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $155,219 - $187,660	2,344 Added 6.43%	38,806 $3.1 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $666,482 - $755,028	10,166 Added 38.66%	36,462 $2.64 Million
Q2 2018 Oct 02, 2018	BUY	$57.57 - $63.54 $746,049 - $823,414	12,959 Added 97.17%	26,296 $1.6 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $121,768 - $137,673	2,164 Added 19.37%	13,337 $799,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $5,958 - $6,379	-111 Reduced 0.98%	11,173 $638,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $78,866 - $88,023	-1,641 Reduced 12.7%	11,284 $0
Q2 2017 Aug 14, 2017	BUY	N/A	458 Added 3.67%	12,925 $628,000
Q1 2017 Aug 17, 2017	SELL	N/A	-55,361 Reduced 81.62%	12,467 $554,000
Q1 2017 Aug 14, 2017	BUY	N/A	67,828	67,828 $2.4 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Abbott Laboratories Transaction History